SL

Sarah Luppino

Investor at M Ventures

Barcelona, Catalonia

Overview 

Sarah Luppino is an Investor at M Ventures, specializing in technology investments with a focus on sustainability, frontier tech, and semiconductors. With a background in chemistry and a Doctor of Philosophy from Massachusetts Institute of Technology, she has successfully invested in companies like Concerto Biosciences (Series A) and holds board positions at various organizations, showcasing her expertise in venture capital and strategic decision-making.

Work Experience 

  • Investor, Technology Investments

    2021 - Current

  • Board Director

    2023

  • Board Director

    2022

Concerto Biosciences reinvents humanity's relationship with microbes.

Raised $26,006,949.00 from Springboard Enterprises.

  • Board Observer

    2022

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

Raised $22,756,543.00 from Pace Ventures, TRAC, Metaplanet, Ultratech Capital Partners and TRAC.

  • Board Director

    2022

Altoida is creating a new gold standard in brain health with Precision Neurology.

Raised $24,749,815.00 from M Ventures, VI Partners, Alpana Ventures, b2venture, Whitecap Venture Partners, FYRFLY Venture Partners, Hikma Ventures and HonorHealth.

  • Consultant

    2019 - 2020

  • Senior Associate Consultant

    2018 - 2019

  • Energy & Sustainability Analyst

    2017 - 2018

    inodu leads studies for public and private sectors in Chile related to power generation, energy & water policy, electricity auctions, and renewable energy project finance & development

  • PhD Candidate

    2012 - 2017

    PhD dissertation on synthesis of organic molecules for solar, sensing, and lighting applications

  • Graduate Teaching Assistant

    2012 - 2013

  • Visiting Ph.D. Researcher

    2016 - 2016

    Collaboration MIT-University of Pisa

Articles About Sarah

Relevant Websites